Homestead Advisers’s Aerie Pharmaceuticals AERI Stock Holding History

Homestead Advisers’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-155,838	Closed	-$1.78M	–	140
2021 Q3	$1.78M	Buy	155,838 +4,200	+3%	+$61.4K	0.04%	104
2021 Q2	$2.43M	Hold	151,638	–	–	0.06%	105
2021 Q1	$2.71M	Buy	151,638 +32,000	+27%	+$553K	0.06%	102
2020 Q4	$1.62M	Sell	119,638 -2,400	-2%	-$29K	0.04%	101
2020 Q3	$1.44M	Buy	122,038 +72,500	+146%	+$883K	0.04%	99
2020 Q2	$731K	Sell	49,538 -600	-1%	-$8.88K	0.02%	99
2020 Q1	$677K	Sell	50,138 -1,170	-2%	-$22.2K	0.02%	96
2019 Q4	$1.24M	Buy	+51,308	New	+$1.06M	0.03%	95

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Homestead Advisers's AERI Position: Q4 2021 in Review

Homestead Advisers sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 155,838 shares — an estimated $1.78M sold.

Homestead Advisers first reported a position in AERI in Q4 2019 and held it in 8 quarters. The position peaked at $2.71M in Q1 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

Homestead Advisers reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Homestead Advisers sold 155,838 Aerie Pharmaceuticals shares in Q4 2021, an estimated $1.78M.
Homestead Advisers first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 8 quarters.
Homestead Advisers's Aerie Pharmaceuticals position peaked at $2.71M in Q1 2021.
129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Homestead Advisers's 13F filing for Q4 2021, filed 7 Feb 2022.